Improve Pharma Opportunity Assessments with Real-World Data
Webinar
Date
April 2, 2020
11:00AM - 12:00PM (GMT-04:00) Atlantic Standard Time
Calendar

Opportunity assessments are used to inform a wide variety of important business decisions for life sciences companies, including product, operational, and investment decisions. However, developing accurate assessments can be notoriously challenging in today's ever evolving and increasingly competitive healthcare environment. Epidemiology sources, primary research, and other traditional sources are key components to understanding pivotal forecast components, but these data points can be time consuming to aggregate and frustrating to validate, especially for complex and changing markets. Real-world data, on the other hand, is readily available in the current healthcare environment and is grounded in reality.

This webinar will show how RWD can be leveraged to improve confidence in opportunity assessments and better inform strategic decision-making. We will walk through the multiple ways to innovatively apply RWD to strategic business questions, presenting IQVIA case studies to highlight the methodologies and insights that can inform the assessment process.

Key take-aways:

  • Knowledge of the variety of RWD sources available and the breadth of strategic business questions they can help address
  • Illustrative case studies demonstrating how RWD can be applied to generate more predictive and prescriptive insights
  • Guiding principles to enable effective use of RWD in forecasts and valuations

SPEAKERS

David Wolter
Vice President Consulting, IQVIA

William Leaf-Herrmann
Senior Principal Consulting, IQVIA

Chip Dolaway
Patient Analytics CoE Lead, IQVIA

Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.

Media Inquiries

Please use this form to reach out to our media team with inquiries. Thank you.